(Adds comments from lawmaker, FDA) By Toni Clarke WASHINGTON, April 26 (Reuters) - The U.S. Food and Drug Administratio...

WASHINGTON — Congressional investigators say pharmacy boards in nearly all 50 states lack the information and expertise to oversee specialty pha...

WASHINGTON — The Food and Drug Administration says it has uncovered potential safety problems at 30 specialty pharmacies that were inspected in ...

WASHINGTON — The head of the Food and Drug Administration asked Congress Wednesday for more authority to police pharmacies like the one that tri...

Lawmakers will hold the first hearings this week to investigate the deadly outbreak of meningitis in the United States. Those hearings represent a step in the right direction, but Congress must follow up with legislative action -- or run the risk that this outbreak will be followed by others.

It will be interesting to see if the current meningitis crisis prompts the federal government to take a fresh look at the rules and regulations governing compounding pharmacies.